Publications by authors named "D V Nebieridze"
Article Synopsis
- - The article provides an overview of earthworm species in Georgia, revealing approximately 90 species from 13 genera found across the country, with a significant concentration in nature reserves.
- - It highlights that 46 of these species are endemic to the Caucasus, indicating the region's unique biodiversity and climatic conditions that contribute to this endemism.
- - Dendrobaena stands out as the most diverse genus among the Caucasian Lumbricidae, comprising 22 species, while several other genera have only one species each, showing variability in species richness.
The review analyzes the possible effect of cardiac drugs on the course of osteoporosis (OP). The fact that atherosclerosis and OP share the mechanisms of development, among which the enhanced activity of the sympathetic part of the autonomic nervous system and endothelial dysfunction are most important, is beyond question now. In this connection, beta-adrenoblockers, nebivolol in particular, attract attention.
View Article and Find Full Text PDFIn this review we give short characteristics of investigations devoted to assessment of effectiveness of cardiac drugs in patients who smoke. Basing on results of these investigations point of view is expressed that antihypertensive preparations of various classes differently affect smokers with arterial hypertension (AH). An opinion exists that drugs which improve endothelial function are preferable in smoking patients with AH.
View Article and Find Full Text PDFAim: Integration of noliprel treatment of arterial hypertension with educational programs on correction of associated risk factors in outpatient practice for reduction of the overall cardiovascular risk.
Material And Methods: An open, multicenter, non-comparative trial with participation of 140 physicians from 14 regions of Russia comprised 1195 patients aged 30-65 years with mild-to-moderate hypertension (SBP = 140-179 mmHg, and/or DBP = 90-109 mm Hg) who had never received regular antihypertensive therapy. This one-year study had an active 3-month stage and follow-up stage for 9 months.